【摘要】 高脂血症是代谢综合征之一，主要包括血液中总胆固醇（Total cholesterol,TC）和（或）三酰甘油（Triglycerides,TG）浓度升高，和（或）高密度脂蛋白（High-density lipoprotein cholesterol,HDL-C）浓度降低，为心脑血管疾患的独立风险因素之一，严重威胁国人身体健康。近年来，各类降脂药，尤其前蛋白转化酶枯草溶菌素9(Proprotein convertase subtilisin/Kexin Type 9,PCSK9)抑制剂，成为研究热点，引起人们的关注。但在中医药持续发展的现状下，中西医联合防治高脂血症已经成为大趋势，并取得一定进展。此文探讨当下高脂血症的中西医治疗现状，以期为临床工作提供助力。更多还原

【Abstract】 Hyperlipidemia is one of the metabolic syndromes. The results mainly included increased levels of total cholesterol(TC)and/or triglycerides(TG), and decreased levels of high-density lipoprotein(HDL-C). As one of the independent risk factors of cardiovascular and cerebrovascular diseases, it seriously threatens the health of Chinese people. In recent years, various lipid-lowering drugs, especially Proprotein Convertase subtilisin Kexin Type 9(PCSK9) inhibitors, have become research hotspots and aroused people’s attention. However, with the continuous development of traditional Chinese medicine, the combined prevention and treatment of hyperlipidemia of traditional Chinese and Western medicine has become the general trend of its treatment direction, and some progress has been made. The purpose of this article is to explore the status of traditional Chinese and Western medicine in the treatment of hyperlipidemia, in order to provide help for clinical work.更多还原